Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers

NCT00479492 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: CP-866,087
DRUG: CP-866,087
DRUG: CP-866,087
DRUG: placebo

Sponsor

Pfizer